User:Mr. Ibrahem/Daridorexant

Daridorexant, sold under the brand name Quviviq, is a medication used to treat trouble sleeping. It is used in those who have had problems for at least three months and is only recommended short term. It is taken by mouth half an hour before bed.

Common side effects include headache, sleepiness, and tiredness. Other side effects may include depression, sleep paralysis, and complex sleep behavior. It has a relatively low risk of misuse. It should not be used in those with severe liver problems or narcolepsy. Safety in pregnancy is unclear. It is a dual orexin receptor antagonist (DORA) and works by blocking the action of orexin. It is not a benzodiazepine or Z-drug.

Daridorexant was approved for medical use in the United States and Europe in 2022. In the United States a month of medication costs about 470 USD as of 2022. It is not commercially available in the United Kingdom as of 2022. It is a schedule IV controlled substance in the United States.